Startseite Crystal structure of (E)-2-((Z)-2-((1S,4R)-3,3-dimethylbicyclo[2.2.1] heptan-2-ylidene)ethylidene)hydrazine-1-carbothioamide, C24H38N6S2
Artikel Open Access

Crystal structure of (E)-2-((Z)-2-((1S,4R)-3,3-dimethylbicyclo[2.2.1] heptan-2-ylidene)ethylidene)hydrazine-1-carbothioamide, C24H38N6S2

  • Jia-Yu Chang ORCID logo , Qing-Ying Ding , Zhuan-Quan Xiao , Ji Zhang EMAIL logo und Shang-Xing Chen ORCID logo EMAIL logo
Veröffentlicht/Copyright: 14. Februar 2023

Abstract

[C24H38N6S2], triclinic, P 1 (no. 2), a = 5.9953(4) Å, b = 7.6132(5) Å, c = 15.3709(10) Å, α = 82.089(5)°, β = 88.307(6)°, γ = 75.992(6)°, V = 674.24(8) Å3, Z = 1, Rgt(F) = 0.0587, wRref(F2) = 0.1516, T = 296(2) K.

CCDC no.: 2238151

The molecular structure is shown in the figure. Table 1 contains crystallographic data and Table 2 contains the list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal: Yellow block
Size: 0.22 × 0.17 × 0.11 mm
Wavelength: Mo Kα radiation (0.71073 Å)
μ: 0.22 mm−1
Diffractometer, scan mode: Bruker APEX-II, φ and ω
θmax, completeness: 25.5°, >99%
N(hkl)measured, N(hkl)unique, Rint: 4725, 2511, 0.018
Criterion for Iobs, N(hkl)gt: Iobs > 2 σ(Iobs), 1848
N(param)refined: 147
Programs: Bruker [1], SHELX [2, 3], Diamond [4]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

Atom x y z Uiso*/Ueq
C1 −0.1324 (4) 0.8262 (3) 0.45895 (16) 0.0465 (6)
C2 0.3706 (4) 0.7104 (4) 0.33877 (17) 0.0497 (7)
H2 0.4373 0.6039 0.3754 0.060*
C3 0.4842 (4) 0.7598 (4) 0.25927 (17) 0.0514 (7)
H3 0.4315 0.8777 0.2303 0.062*
C4 0.6588 (4) 0.6503 (4) 0.22364 (16) 0.0479 (6)
C5 0.7911 (5) 0.4605 (4) 0.26217 (19) 0.0688 (9)
H5 0.7797 0.4323 0.3261 0.083*
C6 0.7236 (6) 0.3264 (5) 0.2100 (2) 0.0829 (10)
H6A 0.5583 0.3541 0.2019 0.099*
H6B 0.7758 0.2020 0.2389 0.099*
C7 0.8456 (7) 0.3538 (5) 0.1227 (2) 0.0809 (10)
H7A 0.9620 0.2447 0.1138 0.097*
H7B 0.7372 0.3843 0.0741 0.097*
C8 0.9524 (5) 0.5095 (4) 0.13090 (19) 0.0646 (8)
H8 1.0753 0.5201 0.0885 0.078*
C9 0.7661 (5) 0.6906 (4) 0.13376 (17) 0.0536 (7)
C10 1.0361 (5) 0.4583 (5) 0.2275 (2) 0.0818 (11)
H10A 1.1415 0.3389 0.2387 0.098*
H10B 1.1007 0.5502 0.2482 0.098*
C11 0.5880 (6) 0.7338 (5) 0.06091 (19) 0.0805 (10)
H11A 0.4839 0.8497 0.0655 0.121*
H11B 0.5039 0.6404 0.0662 0.121*
H11C 0.6635 0.7385 0.0050 0.121*
C12 0.8804 (6) 0.8502 (5) 0.1311 (2) 0.0826 (10)
H12A 0.7652 0.9602 0.1366 0.124*
H12B 0.9594 0.8644 0.0763 0.124*
H12C 0.9883 0.8262 0.1787 0.124*
N1 0.1775 (4) 0.8110 (3) 0.36033 (14) 0.0514 (6)
N2 0.0735 (3) 0.7359 (3) 0.43221 (13) 0.0520 (6)
H2A 0.1403 0.6312 0.4600 0.062*
N3 −0.2120 (4) 0.9950 (3) 0.42077 (15) 0.0662 (7)
H3A −0.1327 1.0424 0.3807 0.079*
H3B −0.3432 1.0578 0.4359 0.079*
S1 −0.27329 (13) 0.72322 (10) 0.53885 (5) 0.0726 (3)

Source of materials

Thiosemicarbazide (0.05 mol) was dissolved in an ethanol aqueous solution (60 mL, VETOH: VH2O = 1:1), and after stirring for 15 min at 50 °C, formylcamphene (0.05 mmol) was added slowly. The mixture was stirred at 40–45 °C for additional 24 h. The reaction solution was cooled and allowed to stand for 1–2 h. The mixture was filtered to give a solid and washed with petroleum ether (3 * 100 mL). The crude product was recrystallized by ethanol. Crystals of the title compound were obtained by slow evaporation in ethyl acetate within one week.

Experimental details

All H atoms were included in calculated positions and refined as riding atoms, with C–H = 0.90–0.97 Å with Uiso(H) = 1.5 Ueq(C) for methyl H atoms and 1.2 Ueq(C) for all other H atoms.

Comment

Thiosemicarbazone compounds are important synthetic drug intermediates [5], [6], [7]. For instance, Zhang et al. have synthesized (E)-1-(4-fluorobenzyl)-4-(4-ethylphenyl) thiobarbazone by the reaction of 4-(4-ethylphenyl)thiobarbazone with 4-fluorobenzaldehyde [8]. Murat Doğan et al. have synthesized 22 thiosemicarbazone derivatives and evaluated their biological activity [9]. However, most of thiosemicarbazone compounds from these studies have a monocyclic or chain structure, and relatively few studies have been reported on the synthesis and biological activity of their aminothioureas with a bicyclic structure. Based on this point, a novel bicyclic structure-containing condensed aminothiourea compound was synthesized from ω-formyl camphene, and its crystal structure was characterized.

In the molecules of the title structure bond lengths and angles are very similar to those given in the literature for (−)-camphene derivatives [10, 11]. The dihedral angles formed by the C5–C8 plane, the C4–C5–C8–C9 plane and the C5–C8–C10 plane are 58°, 66° and 56°. The torsion angles of C5–C4–C3–C2, C4–C3–C2–N1, C3–C2–N1–N2, C2–N1–N2–C1, N1–N2–C1–N3 and N1–N2–C1–S1 are −7°, −167°, 172°, −178°, −8°, and 173°, respectively.


Corresponding authors: Ji Zhang and Shang-Xing Chen, College of Forestry, East China Woody Fragrance and Flavor Engineering Research Center of National Forestry and Grassland Administration, Jiangxi Agricultural University, Nanchang 330045, People’s Republic of China, E-mail: ;

Funding source: National Natural Science Foundation of China

Award Identifier / Grant number: 31960295

Funding source: Major science and technology R & D special project

Award Identifier / Grant number: 20203ABC28W016

Funding source: Jiangxi Province Training Program Leading Talents Project

Award Identifier / Grant number: 20204BCJ22022

Funding source: Central Finance Forestry Science and Technology Promotion Demonstration Fund Project

Award Identifier / Grant number: JXTG(2021)01

Acknowledgements

X-ray data were collected at Instrumental Analysis Center Nanchang Hangkong University, Nanchang, 330063, People’s Republic of China.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was supported by the National Natural Science Foundation of China (No. 31960295), Major science and technology R & D special project (20203ABC28W016), Jiangxi Province Training Program Leading Talents Project (20204BCJ22022) and Central Finance Forestry Science and Technology Promotion Demonstration Fund Project (JXTG(2021)01).

  3. Conflict of interest statement: The authors declare no conflicts of interest regarding this article.

References

1. Bruker. APEX2, SAINT and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2009.Suche in Google Scholar

2. Sheldrick, G. M. A short history of SHELX. Acta Crystallogr. 2008, A64, 112–122. https://doi.org/10.1107/s0108767307043930.Suche in Google Scholar PubMed

3. Sheldrick, G. M. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8. https://doi.org/10.1107/s2053229614024218.Suche in Google Scholar

4. Brandenburg, K. DIAMOND. Visual Crystal Structure Information System. Ver. 4.0; Crystal Impact: Bonn, Germany, 2015.Suche in Google Scholar

5. Shahsavani, E., Feizi, N., Eigner, V., Dusek, M., Khalaji, A. D. Crystal structure of copper(I) thiosemicarbazone complex [CuI(PPh3)(catsc)]. J. Struct. Chem. 2015, 56, 1003–1007. https://doi.org/10.1134/S0022476615050273.Suche in Google Scholar

6. Naesborg, L., Halskov, K. S., Tur, F., Monsted, S. M. N., Joergensen, K. A. Asymmetric γ-allylation of α,β-unsaturated aldehydes by combined organocatalysis and transition-metal catalysis. Angew. Chem. Int. Ed. 2015, 54, 10193–10197. https://doi.org/10.1002/anie.201504749.Suche in Google Scholar PubMed

7. Arfan, A., Rukiah, M. Crystal structures of crotonaldehyde semicarbazone and crotonaldehyde thiosemicarbazone from X-ray powder diffraction data. Acta Crystallogr. 2015, E71, 168–172. https://doi.org/10.1107/S2056989015000663.Suche in Google Scholar PubMed PubMed Central

8. Zhang, X., Huang, J., Zhang, Y., Qi, F., Wang, S. F., Song, J. R. Synthesis, crystal structure and non-covalent interactions analysis of novel N-substituted thiosemicarbazone. Chem. Res. Chin. Univ. 2019, 35, 471–477. https://doi.org/10.1007/s40242–019–8354–8.10.1007/s40242-019-8354-8Suche in Google Scholar

9. Doğan, M., Koçyiğit, Ü. M., Gürdere, M. B., Ceylan, M., Budak, Y. Synthesis and biological evaluation of thiosemicarbazone derivatives. Med. Oncol. 2022, 39, 157. https://doi.org/10.1007/s12032–022–01784-y.10.1007/s12032-022-01784-ySuche in Google Scholar PubMed

10. Moews, P. C., Knox, J. R., Vaughan, W. R. Camphene. 5. Torsion factors influencing exo/endo Nametkin rearrangement. The structure of (-)-camphene-8-carboxylic acid. J. Am. Chem. Soc. 1978, 100, 260–264. https://doi.org/10.1021/ja00469a043.Suche in Google Scholar

11. Davis, F. A., Boyd, R., Zhou, P., Abdul-Malik, N. F., Carroll, P. J. (+)-trans-camphenesulfonamide: a novel enantiomerically pure primary sulfonamide. Tetrahedron Lett. 1996, 37, 3267–3270. https://doi.org/10.1016/0040–4039(96)00567–9.10.1016/0040-4039(96)00567-9Suche in Google Scholar

Received: 2023-01-06
Accepted: 2023-01-26
Published Online: 2023-02-14
Published in Print: 2023-04-25

© 2023 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. New Crystal Structures
  3. The crystal structure of methyl 2-((4-chloro-2-fluoro-6-((2,2,2-trifluoroethyl) thio)phenoxy)methyl)benzoate, C17H13ClF4O3S
  4. The crystal structure of 3-hydroxy-5-oxo-4-propanoylcyclohex-3-ene-1-carboxylic monohydrate, C10H14O6
  5. Crystal structure of 2-({[5-(adamantan-2-yl)-2-sulfanylidene-1,3,4-oxadiazolidin-3-yl]methyl}amino)benzonitrile, C20H22N4OS
  6. Crystal structure of 1-(3-bromopropyl)-2-((4-chlorophenoxy)methyl)-4-methyl-1H-benzo[d]imidazole, C18H18BrClN2O
  7. Crystal structure of 2-methoxy-6-[(2-morpholin-4-yl-phenylamino)-methylene]-4-nitro-cyclohexa-2,4-dienone, C18H19N3O5
  8. The crystal structure of 2-(7-(2,3-dimethoxyphenyl)-[1,2,4]triazolo[1,5-a]-pyrimidin-5-yl)-3-methoxyphenol, C20H18N4O4
  9. The crystal structure of 3-(1-(2-(4-hydroxy-3,5-dimethoxybenzylidene)hydrazinyl)ethylidene)chroman-2,4-dione dihydrate, C20H22N2O8
  10. Crystal structure of 3,5,7-trimethoxy-3′,4′-methylenedioxy-flavone, C19H16O7
  11. The crystal structure of strictic acid, C20H26O3
  12. Crystal structure of 1,1′-(pyrazine-1,4-diyl)-bis(propan-2-one), C10H14N2O2
  13. The crystal structure of 1-(adamantan-1-yl)-3-(4-chlorophenyl)urea, C17H21ClN2O
  14. The crystal structure of (2R,6′R)-2′,7-dichloro-4,6-dimethoxy-6′-methyl-3H-spiro[benzofuran-2,1′-cyclohexan]-2′-ene-3,4′-dione, C16H14Cl2O5
  15. Synthesis and crystal structure of 1-((3R,10S,13R,17S)-3-((4-methoxyphenyl)amino)-10,13-dimethylhexadecahydro-1H-cyclopenta[α]-phenanthren-17-yl)ethan-1-one, C28H41NO2
  16. Crystal structure of N-2,6-difluorobenzoyl-N′-[1-(3-chloro-4-methyl-phenyl)-4-cyano-1H-pyrazol-5-carbamoyl]urea, C19H12ClF2N5O2
  17. Crystal structure of (−)-β-D-19-glucopiranosyl-9,15-dihydroxy kaurenoate, C26H40O9
  18. Crystal structure of 7-hydroxy-6-(2-hydroxyethyl)-2H-chromen-2-one, C11H10O4
  19. Crystal structure of S-(benzo[d]thiazol-2-yl)-N-(tert-butyl)thiohydroxylamine, C11H14N2S2
  20. Crystal structure of poly[di-µ2-aqua-aqua-nitrato-κ2O,O′-(µ3-2-nitroisophthalato-κ4O,O′:O″:O′″)barium(II)natrium(II)] monohydrate, C8H11BaN2NaO13
  21. The crystal structure of diaqua-bis(pyrazolo[1,5-a]pyrimidine-3-carboxylato-κ2 N,O)-cobalt(II) dihydrate, C14H16N6O8Co
  22. Crystal structure of (S,E)-3-((pyridin-2-ylmethylene)amino)-2-(pyridin-4-yl)-2,3- dihydroquinazolin-4(1H)-one monohydrate, C19H15N5O⋅H2O
  23. Synthesis and crystal structure of 5-(8-(((5-carboxypentyl)ammonio)methyl)-7-hydroxy-4-oxo-4H-chromen-3-yl)-2-hydroxy-3-nitrobenzenesulfonate monohydrate, C22H24N2O12S
  24. Synthesis and crystal structure of 8-bromo-3-(1H-pyrazole-1-carbonyl)-2H-chromen-2-one, C13H7BrN2O3
  25. Crystal structure of E-7-fluoro-2-(4-methoxy-3-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C19H14F4O2
  26. Hydrogen bonded dimers in the crystal structure of 2-chloro-N-((3,5-dimethylphenyl)carbamoyl)-nicotinamide, C30H28Cl2N6O4
  27. Crystal structure of 3,3′-(1,4-phenylenebis(methylene))bis(1-allyl-1H-imidazol-3-ium) bis(hexafluoro phosphate)(V), C10H12F6N2P
  28. Crystal structure of (E)-7-bromo-2-(4-(4-methylpiperazin-1-yl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23BrN2O
  29. Crystal structure of pentacarbonyl-(μ2-ethane-1,2-dithiolato-κ4S:S,S′:S′)-(diphenyl(o-tolyl)phosphine-κ1P)diiron (Fe–Fe), C26H21Fe2O5PS2
  30. Crystal structure of 9-(2-chloroethoxy)-4-(4-methoxy-3-(trifluoromethyl)phenyl)- 5,6-dihydrobenzo[h]quinazolin-2-amine, C22H19ClF3N3O2
  31. Crystal structure of triaqua-[5-bromo-2-(carboxylatomethoxy)benzoate-κ3 O,O′,O″]nickel(II), C9H11BrNiO8
  32. The crystal structure of 4,4′-dichloro-3,5′-diphenyl-1′H-1,3′- bipyrazole, C18H12Cl2N4
  33. The crystal structure of bis(1H-pyrazole-carboxamidine-κN,N′)bis(nitrato-κO)-copper(II), C8H12CuN10O6
  34. Synthesis and crystal structure of 3-bromo-4-phenyl-2H-chromene, C15H11BrO
  35. Crystal structure of (E)-5-(diethylamino)-2-((morpholinoimino)methyl)phenol, C15H23N3O2
  36. Crystal structure of niobium trigallide, NbGa3
  37. Crystal structure of dimethyl 4,4′-(((1R, 2R)-cyclohexane-1,2-diyl)bis(azanediyl))dibenzoate, C22H26N2O4
  38. Crystal structure of dimethyl 4,4′-((4R, 5R)-4,5-diphenylimidazolidine-1,3-diyl)dibenzoate, C31H28N2O4
  39. The crystal structure of 2-(2-bromophenyl)-4-phenylbenzo[b][1,4]oxaphosphinine 4-oxide, C20H14BrO2P
  40. The crystal structure of 3-hydroxy-2-nitroestra-1,3,5(10)-trien-17-one, C18H21NO4
  41. Crystal structure of catena-poly[[μ2-1,3-bis[(1H-imidazol-1- yl)methyl]benzene-N:N′]-(μ2–D–camphorato-O, O′: O″, O‴)cadmium(II)], C48H56Cd2N8O8
  42. Crystal structure of N-(4-bromophenyl)-4-[3-(trifluoromethyl)phenyl]-piperazine-1-carbothioamide, C18H17BrF3N3S
  43. The crystal structure of cis-Dicyano-bis(2,2′-bipyridine)k2N,N′-chromium(III) hexafluorophosphate, C22H16N6F6PCr
  44. Crystal structure of 4-((6-bromohexyl)oxy)-2-hydroxybenzaldehyde, C13H17BrO3
  45. Crystal structure of hydrazinium methanesulfonate, CH8N2O3S
  46. Crystal structure of 1-(2-iodobenzoyl)-6-methoxy-1H-indole-3-carbaldehyde, C17H12INO3
  47. Crystal structure of bis(acridinium) tetrabromidomanganate(II), C26H20Br4MnN2
  48. The crystal structure of 6,6′-((1E,1′E)-hydrazine-1,2-diylidenebis(methanylylidene)) bis(2-(tert-butyl)phenol), C22H28N2O2
  49. The crystal structure of the cocrystal di-μ2-chlorido-tetramethyl-tetraphenyl-di-μ3-oxido-dichloridotetratin(IV) – diphenyl-methyl-chloridotin(IV)(1/2), C54H58Cl6O2Sn6
  50. Crystal structure of (3a7R,13bR)-3-((1R)-1-hydroxy-1-(5-methyl-6-oxo-3,6-dihydro-2H-pyran-2-yl)ethyl)-3a,11,11,13b-tetramethyl-2,3,3a,4,5,11,11a,12,13,13b-decahydroindeno[5′,4′:4,5] cyclohepta[1,2-c]oxepin-9(1H)-one, C30H40O5
  51. Crystal structure of 1-(4-methoxyphenyl)-2-phenoxyethan-1-one, C15H14O3
  52. Crystal structure of trans-tetrakis(3-phenylpyridine-κN)bis(thiocyanato-κN)nickel(II), C46H36N6NiS2
  53. Crystal structure of sodium catena-poly[bis(thiourea-κ1S)-tetrakis(μ2-thiourea-κ2S,S)tricopper(I)] difumarate, C14H29Cu3N12NaO8S6
  54. Crystal structure of bis(benzylamine-κ1N)-bis((E)-2-methyl-3-phenylacrylato-κ1O)copper(II), C34H36CuN2O4
  55. The crystal structure of 3,4-dihydroxybenzoic acid – 3-[7-{[2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3] triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol – water (1/1/1), C30H36F2N6O9S
  56. Crystal structure of catena-poly[dipyridine-bis(pyridine-2-carboxylato-κ 2 N,O)-bis(μ 2-pyridine-2-carboxylato-κ 2 N,O)-dinickel(II)], C34H26N6Ni2O8
  57. The crystal structure of 1-((1-methyl-1H-1,2,4-triazol-3-yl) methyl)-3-(2,4,5-trifluorobenzyl)-1,3,5-triazinane-2,4,6-trione, C14H11F3N6O3
  58. Crystal structure of (E)-2-((Z)-2-((1S,4R)-3,3-dimethylbicyclo[2.2.1] heptan-2-ylidene)ethylidene)hydrazine-1-carbothioamide, C24H38N6S2
  59. Crystal structure of photochromic 3-(5-(2,5-dimethylthiophen-3-yl)-2,2,3,3,4,4-hexafluorocyclopentyl)-2-methylbenzo[b]-thiophene, C20H14F6S2
  60. Crystal structure of bis(2,5,5,7-tetramethyl-1,4-diazepane-1,4-diium) diaqua-bis(1,2-diaminopropane)copper(II) bis(μ6-oxido)tetrakis(μ3-oxido)-tetradecakis(μ2-oxido)-octaoxido-decavanadium(V) – water (1/4), C24H76CuN8V10O34
  61. Crystal structure of 1,2,3,5,13-pentamethoxy-6,7-dimethyl-1,2,3,4,4a,5,6,7,8,13b-decahydrobenzo[3′,4′]cycloocta[1′,2′:4,5]benzo[1,2-d][1,3]dioxole, C24H30O7
  62. Crystal structure of bis(6-carboxyhexyl)-4,4′-bipyridinium dibromide – 2,6-dihydroxynaphthalene (1/2), C42H46Br2N2O8
  63. Crystal structure of methyl 2-(2-chloroacetyl)-1-(4-(methoxycarbonyl)phenyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b] indole-3-carboxylate, C23H21ClN2O5
  64. Crystal structure of bis(dimethylammonium) poly[{μ4-1,1ʹ-(1,4-phenylenebis(methylene))bis(1H-pyrazole-3,5-dicarboxylato)-κ6N4O2}zinc(II)], C22H26N6O8Zn
  65. Crystal structure of 2-(2-(4-methoxyphenyl)-2H-indazol-3-yl)acetonitrile, C16H13N3O
  66. Crystal structure of (E)-7-methoxy-2-(4-morpholinobenzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H23NO3
  67. The crystal structure of N′1,N′2-bis((E)-3-(tert-butyl)-2-hydroxybenzylidene)oxalohydrazide, C24H30N4O4
  68. The crystal structure of trimethyl 2,2′,2′′-(benzene-1,3,5-triyltris(oxy))triacetate, C15H18O9
  69. Crystal structure of bis(N,N-dimethylformamide-κO)-bis(pyridine-2-carboxylato-κ2N,O)-bis(μ2-pyridine-2-carboxylato-κ2N,O)-dinickel(II), C30H30N6Ni2O10
  70. Crystal structure of bis(μ2-1-pyrenecarboxylato-κ3O,O′:O′)-bis(1-pyrenecarboxylato-κ2O,O′)-(benzimidazole-κ1N)dicadmium(II), C82H48Cd2N4O8
  71. One-pot synthesis and crystal structure of diethyl 2,6-dimethyl-4-(1-(2-nitrophenyl)-1H-1,2,3-triazol-4-yl)-1,4-dihydropyridine-3,5-dicarboxylate, C21H23N5O6
  72. The crystal structure of 1-(2-fluorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-carbonitrile, C18H13FN2O2
  73. Crystal structure of bis(trimethylphenylammonium) aqua-oxido-octathiotritungstate, (Me3PhN)2[W3OS8(H2O)]
  74. The crystal structure of trichlorido[N-[(2-oxyphenyl)methylidene]phenylglycinemethylester-κ3O,N,O′]-tin(IV) – methylene chloride (1/1), C16H14Cl3NO3Sn·CH2Cl2
  75. The crystal structure of furan-2,5-diylbis((4-chlorophenyl)methanol), C18H14Cl2O3
  76. The crystal structure of hexalithium decavanadate hexadecahydrate, H32Li6O44V10
  77. Crystal structure of ethyl 4-{[5-(adamantan-1-yl)-2-sulfanylidene-2,3-dihydro-1,3,4-oxadiazol-3-yl]methyl}piperazine-1-carboxylate, C20H30N4O3S
  78. Crystal structure of aqua(μ2-2,2′,2″-((nitrilo)tris(ethane-2,1-diyl(nitrilo)methylylidene))tris (6-ethoxyphenolato))(pentane-2,4-dionato-κ2O,O′)-dinickel(II), C38H48N4Ni2O9
Heruntergeladen am 8.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2023-0011/html
Button zum nach oben scrollen